Published in Trends Biotechnol on February 21, 2007
Shape-controlled synthesis of metal nanocrystals: simple chemistry meets complex physics? Angew Chem Int Ed Engl (2009) 5.12
Nanomedicine--challenge and perspectives. Angew Chem Int Ed Engl (2009) 2.74
Limitations on the optical tunability of small diameter gold nanoshells. Langmuir (2009) 0.93
Correlated Optical Spectroscopy and Transmission Electron Microscopy of Individual Hollow Nanoparticles and their Dimers. J Phys Chem C Nanomater Interfaces (2008) 0.86
Chemoresistive gas sensors for the detection of colorectal cancer biomarkers. Sensors (Basel) (2014) 0.81
Green Synthesis of Metallic Nanoparticles via Biological Entities. Materials (Basel) (2015) 0.79
Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders. Dig Liver Dis (2013) 0.78
Gold nanoparticles grown inside carbon nanotubes: synthesis and electrical transport measurements. Nanoscale Res Lett (2014) 0.77
Interfacing Cultured Neurons to Microtransducers Arrays: A Review of the Neuro-Electronic Junction Models. Front Neurosci (2016) 0.77
Deregulation of the miR-16-KRAS axis promotes colorectal cancer. Sci Rep (2016) 0.75
Current applications and future prospects of nanomaterials in tumor therapy. Int J Nanomedicine (2017) 0.75
Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model. J Nanobiotechnology (2016) 0.75
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29
Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett (2005) 6.02
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell (2007) 5.40
Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat (2004) 4.06
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol (2008) 3.02
Point: developing a curriculum in clinical pathology. Clin Chem (2006) 2.92
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol (2011) 2.78
Single- and multiple-dose pharmacokinetics of caspofungin in healthy men. Antimicrob Agents Chemother (2002) 2.68
A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer (2007) 2.64
Metal nanoshells. Ann Biomed Eng (2006) 2.44
Concordance study of 3 direct-to-consumer genetic-testing services. Clin Chem (2010) 2.33
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol (2010) 2.30
Improving healthcare accessibility through point-of-care technologies. Clin Chem (2007) 2.11
Validation of the quality of ultrasound imaging and competence (QUICk) score as an objective assessment tool for the FAST examination. J Trauma Acute Care Surg (2015) 2.00
MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A (2007) 1.90
p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A (2009) 1.89
Label-free biomarker detection from whole blood. Nat Nanotechnol (2009) 1.80
Tailored navigation in colorectal cancer screening. Med Care (2008) 1.79
Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med (2004) 1.68
Gold nanoshell bioconjugates for molecular imaging in living cells. Opt Lett (2005) 1.64
Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity. Gastroenterology (2007) 1.63
G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans. Hypertension (2009) 1.62
Surface-enhanced Raman spectroscopy of DNA. J Am Chem Soc (2008) 1.61
Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer. Clin Cancer Res (2011) 1.59
First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 1.55
Diagnostic challenges for multiplexed protein microarrays. Drug Discov Today (2006) 1.54
Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology (2012) 1.53
Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. Cancer Res (2009) 1.52
Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy. Eur J Immunol (2014) 1.49
High-resolution SNP arrays in mental retardation diagnostics: how much do we gain? Eur J Hum Genet (2009) 1.46
Competitive hybridization kinetics reveals unexpected behavior patterns. Biophys J (2005) 1.45
Digital mRNA profiling. Nat Biotechnol (2008) 1.43
A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer. Clin Cancer Res (2006) 1.42
Eltrombopag and serum of a different hue. Arch Pathol Lab Med (2013) 1.42
Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med (2009) 1.41
Laboratory-based vascular anastomosis training: a randomized controlled trial evaluating the effects of bench model fidelity and level of training on skill acquisition. J Vasc Surg (2007) 1.40
Value of debriefing during simulated crisis management: oral versus video-assisted oral feedback. Anesthesiology (2006) 1.39
Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol (2005) 1.39
Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev (2005) 1.38
Teaching suturing and knot-tying skills to medical students: a randomized controlled study comparing computer-based video instruction and (concurrent and summary) expert feedback. Surgery (2007) 1.37
Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract. Hum Pathol (2005) 1.32
The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Clin Cancer Res (2005) 1.31
Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg (2009) 1.29
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing. Blood (2011) 1.28
The transcription factor encyclopedia. Genome Biol (2012) 1.28
Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine. Am J Pathol (2007) 1.28
A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. J Clin Invest (2011) 1.27
Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet (2003) 1.27
S.T.A.R.T.T.: development of a national, multidisciplinary trauma crisis resource management curriculum-results from the pilot course. J Trauma Acute Care Surg (2013) 1.22
Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer. JAMA (2009) 1.21
Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med (2003) 1.21
Differences in the perceived impact of sleep deprivation among surgical and non-surgical residents. Med Educ (2008) 1.21
Translating MicroRNA discovery into clinical biomarkers in cancer. JAMA (2007) 1.20
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma. Cancer (2011) 1.18
Controlled texturing modifies the surface topography and plasmonic properties of Au nanoshells. J Phys Chem B (2005) 1.18
Racial differences in severe perineal lacerations after vaginal delivery. Am J Obstet Gynecol (2003) 1.17
Quantification of motion characteristics and forces applied to tissues during suturing. Am J Surg (2005) 1.17
Cu nanoshells: effects of interband transitions on the nanoparticle plasmon resonance. J Phys Chem B (2005) 1.16
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocr Relat Cancer (2010) 1.16
Cell stimulation with optically manipulated microsources. Nat Methods (2009) 1.15
Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. J Clin Pharmacol (2003) 1.15
Evaluation of a scaling approach for the bioequivalence of highly variable drugs. AAPS J (2008) 1.15
Microfluidics and point-of-care testing. Lab Chip (2008) 1.15
GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity. PLoS One (2012) 1.13
Micropillar array chip for integrated white blood cell isolation and PCR. Biomol Eng (2005) 1.13
GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur J Cancer (2011) 1.13
Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment. Am J Pathol (2011) 1.12
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity. J Natl Cancer Inst (2008) 1.12
Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. Am J Pathol (2010) 1.11
Selection of optimal reference genes for normalization in quantitative RT-PCR. BMC Bioinformatics (2010) 1.11
Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo. Int J Cancer (2010) 1.10
Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers. J Clin Pharmacol (2006) 1.09
Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology (2006) 1.09
Next-generation sequencing in the clinic. Nat Biotechnol (2013) 1.09
Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg (2008) 1.08
Whole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donor. BMC Genomics (2011) 1.08
A study of career choice patterns among Canadian medical students. Am J Surg (2003) 1.08
Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. J Mol Cell Cardiol (2004) 1.07
Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer. Expert Rev Mol Diagn (2005) 1.07
Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck (2009) 1.07
Indinavir and rifabutin drug interactions in healthy volunteers. J Clin Pharmacol (2004) 1.05
Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene. Cancer Res (2010) 1.04
Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer (2013) 1.03
Structured assessment format for evaluating operative reports in general surgery. Am J Surg (2008) 1.03
Relative quantification based on logistic models for individual polymerase chain reactions. Stat Med (2007) 1.02
Erythroid-induced commitment of K562 cells results in clusters of differentially expressed genes enriched for specific transcription regulatory elements. Physiol Genomics (2004) 1.02
Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Cancer Res (2009) 1.01
Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association. Circulation (2013) 1.01
A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes? J Gastrointest Surg (2012) 1.00
Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling. Circulation (2011) 1.00
Quality control and protein microarrays. Clin Chem (2009) 0.98
Nanosystems for simultaneous imaging and drug delivery to T cells. AAPS J (2007) 0.98